PHARMACEUTICAL | DRY EYE
Acoltremon Ophthalmic Solution 0.003%
*Formerly named AR-15512
About Acoltremon
Acoltremon is an agonist of transient receptor potential melastatin 8 (TRPM8), which is a receptor that plays a key role in regulating basal tear production. Acoltremon ophthalmic solution 0.003% is a first-in-class product for the treatment of the signs and symptoms for dry eye disease.
For more information about dry eye disease, please visit
Understanding Dry Eye.
Clinical Trials for Acoltremon Ophthalmic Solution 0.003%*

MANUSCRIPT
*Formerly named AR-15512
© 2025 Alcon Inc. 2025 p-MED-US-NP-250082